|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0024623,
umls-concept:C0030705,
umls-concept:C0034802,
umls-concept:C0037657,
umls-concept:C0069515,
umls-concept:C0185117,
umls-concept:C0242957,
umls-concept:C0332307,
umls-concept:C1274040,
umls-concept:C2911684
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-5-16
|
|
pubmed:abstractText |
Expression levels of insulin-like growth factor type 1 receptor (IGF-IR), epidermal growth factor receptor (EGFR), and HER2 expressions have been linked to clinical outcomes in several solid tumors. However, the clinical significance of these biomarkers in gastric cancer (GC) remains unclear. This study was designed to delineate the clinical implications of these three biomarkers in GC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3022-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18483367-Adenocarcinoma,
pubmed-meshheading:18483367-Adult,
pubmed-meshheading:18483367-Aged,
pubmed-meshheading:18483367-Aged, 80 and over,
pubmed-meshheading:18483367-Antineoplastic Agents,
pubmed-meshheading:18483367-Female,
pubmed-meshheading:18483367-Gene Expression,
pubmed-meshheading:18483367-Humans,
pubmed-meshheading:18483367-Immunohistochemistry,
pubmed-meshheading:18483367-Kaplan-Meier Estimate,
pubmed-meshheading:18483367-Male,
pubmed-meshheading:18483367-Middle Aged,
pubmed-meshheading:18483367-Prognosis,
pubmed-meshheading:18483367-Receptor, Epidermal Growth Factor,
pubmed-meshheading:18483367-Receptor, IGF Type 1,
pubmed-meshheading:18483367-Receptor, erbB-2,
pubmed-meshheading:18483367-Stomach Neoplasms,
pubmed-meshheading:18483367-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
|
|
pubmed:affiliation |
Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article
|
